Immunosuppressive effects of L-asparaginase.
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000409:Alanine; D000917:Antibody Formation; D000941:Antigens; D001215:Asparaginase / Q000627:therapeutic use*; D001216:Asparagine; D001943:Breast Neoplasms / Q000188:drug therapy; D002277:Carcinoma / Q000188:drug therapy; D002675:Child, Preschool; D005260:Female; D005971:Glutamates; D006433:Hemocyanins; D006801:Humans; D006968:Hypersensitivity, Delayed; D007136:Immunoglobulins; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D037102:Lectins; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008214:Lymphocytes / Q000276:immunology; D008239:Lysine; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology*; D012516:Osteosarcoma / Q000188:drug therapy; D014443:Tyrosine
D000941:Antigens; D005971:Glutamates; D007136:Immunoglobulins; D007166:Immunosuppressive Agents; D037102:Lectins; D014443:Tyrosine; D001216:Asparagine; D006433:Hemocyanins; D001215:Asparaginase; D008239:Lysine; D000409:Alanine